Ledger.Open graph →
SEC Form D · filed August 26, 2025

Superluminal Medicines, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Diamantis Xylas · WALTHAM, MADirectorDylan Morris · San Fransicso, CADirectorAndrew Levin · BOSTON, MADirectorCony D'Cruz · BOSTON, MAExec · Director · PromoterDylan Morris · Palo Alto, CADirectorAndrew Levin · Boston, MADirectorDiamantis Xylas · WALTHAM, MADirectorCony D'Cruz · BOSTON, MAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗